Macrophage-mimetic nanomedicines for the treatment of diseases

Bwalya A. Witika, Scott K. Matafwali, Pedzisai A. Makoni

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Citation (Scopus)


The use of synthetic encapsulation by applying polymers and lipidic molecules often results in failure to meet clinical expectations. As such, resorting to natural alternatives such as pathogens and mammalian cells appears to be a viable alternative more so because they are exceedingly optimized for their specific functions in vivo. In addition, they are in possession of specific features that are desirable in drug delivery applications. Recently, the role of macrophages in a range of disorders including infectious diseases, inflammatory diseases, cancer, and atherosclerosis has been elucidated and has provided novel strategies to target infected cell types to improve therapeutic outcomes. Macrophages also have the inherent ability of tumor homing, stealth in blood circulation, and phagocytosis of particles. Having developed a better understanding of these roles, in combination with the availability of cutting-edge biotechnology tools that are capable of re-engineering the various natural systems, it has become increasingly plausible to exploit macrophages for multiple applications in the delivery of active therapeutic agents and possibly treat or prevent diseases.

Original languageEnglish
Title of host publicationNanotechnology Principles in Drug Targeting and Diagnosis
Number of pages27
ISBN (Electronic)9780323917636
ISBN (Print)9780323983488
Publication statusPublished - 1 Jan 2023


  • Autoimmunity
  • atherosclerosis
  • biomimetic
  • cancer treatment
  • immune response
  • infectious diseases
  • inflammatory diseases
  • macrophages
  • nanomedicine
  • targeted drug delivery


Dive into the research topics of 'Macrophage-mimetic nanomedicines for the treatment of diseases'. Together they form a unique fingerprint.

Cite this